US20020197828A1 - Method and apparatus for manufacturing a semiconductor device and processing a substrate - Google Patents
Method and apparatus for manufacturing a semiconductor device and processing a substrate Download PDFInfo
- Publication number
- US20020197828A1 US20020197828A1 US10/106,234 US10623402A US2002197828A1 US 20020197828 A1 US20020197828 A1 US 20020197828A1 US 10623402 A US10623402 A US 10623402A US 2002197828 A1 US2002197828 A1 US 2002197828A1
- Authority
- US
- United States
- Prior art keywords
- substrate
- film
- tantalum oxide
- oxide film
- processing chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 111
- 239000000758 substrate Substances 0.000 title claims abstract description 105
- 238000012545 processing Methods 0.000 title claims abstract description 89
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000004065 semiconductor Substances 0.000 title claims description 8
- 239000012535 impurity Substances 0.000 claims abstract description 58
- 230000003647 oxidation Effects 0.000 claims abstract description 4
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 4
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 80
- 229910001936 tantalum oxide Inorganic materials 0.000 claims description 80
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 238000000151 deposition Methods 0.000 claims description 2
- 238000005229 chemical vapour deposition Methods 0.000 abstract description 26
- 239000010408 film Substances 0.000 description 130
- 239000007789 gas Substances 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000012546 transfer Methods 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 4
- 238000000231 atomic layer deposition Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005137 deposition process Methods 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- -1 e.g. Substances 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 1
- HSXKFDGTKKAEHL-UHFFFAOYSA-N tantalum(v) ethoxide Chemical compound [Ta+5].CC[O-].CC[O-].CC[O-].CC[O-].CC[O-] HSXKFDGTKKAEHL-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
- H04B10/29—Repeaters
- H04B10/291—Repeaters in which processing or amplification is carried out without conversion of the main signal from optical form
- H04B10/293—Signal power control
- H04B10/294—Signal power control in a multiwavelength system, e.g. gain equalisation
- H04B10/296—Transient power control, e.g. due to channel add/drop or rapid fluctuations in the input power
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
- C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
- C23C16/40—Oxides
- C23C16/405—Oxides of refractory metals or yttrium
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
- C23C16/4401—Means for minimising impurities, e.g. dust, moisture or residual gas, in the reaction chamber
- C23C16/4405—Cleaning of reactor or parts inside the reactor by using reactive gases
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
- C23C16/54—Apparatus specially adapted for continuous coating
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/56—After-treatment
Definitions
- the present invention relates to a method and apparatus for manufacturing a semiconductor device and processing a substrate.
- FIG. 5 shows a schematic view of a conventional chemical vapor deposition (CVD) apparatus 50 for use in processing a substrate.
- the apparatus 50 includes a heater 2 installed in a reactor chamber (hereinafter also referred to as a processing chamber) 1 , a susceptor 3 positioned above the heater 2 , a shower head 5 having shower holes 6 and installed above the susceptor 3 , a gas inlet 7 jointed above the shower head 5 , and an exhaust port 8 provided at the processing chamber 1 .
- a reactor chamber hereinafter also referred to as a processing chamber
- a susceptor 3 positioned above the heater 2
- a shower head 5 having shower holes 6 and installed above the susceptor 3
- a gas inlet 7 jointed above the shower head 5
- an exhaust port 8 provided at the processing chamber 1 .
- a substrate 4 is mounted on the susceptor 3 positioned in the hermetically sealed processing chamber 1 and is heated by the heater 2 .
- a reactive gas obtained by mixing an evaporated Penta Ethoxy Tantalum (Ta(OC 2 H 5 ) 5 , hereinafter referred to as PET), an oxygen gas and an inert gas is supplied to the substrate 4 after passing through the gas inlet 7 and the shower head 5 .
- a tantalum oxide film is then formed on minute electrical circuit patterns positioned on the substrate 4 by the chemical reaction of the reactive gas that takes place on the substrate 4 .
- an exhausted gas is pumped out from the processing chamber 1 via the exhaust port 8 .
- FIG. 6 there is illustrated a tantalum oxide film 11 grown on the substrate 4 with a step coverage (b/a), a and b representing a film thickness on the top surface of the substrate 4 and that on the bottom of a recess of the substrate 4 , respectively.
- FIG. 7 shows the relationship between a step coverage (b/a) and the substrate temperature during the film growth (referred to as film growth temperature hereinafter).
- the step coverage of the tantalum oxide film 11 is good as shown in FIG. 7 and the tantalum oxide film 11 becomes an amorphous tantalum oxide film (TaO film).
- the film growth temperature is high, the step coverage of the tantalum oxide film 11 is poor and the tantalum oxide film 11 becomes a crystalline tantalum oxide film (Ta 2 O 5 film).
- the film growth temperature is low, e.g., around 440° C., no significant stress is induced in the grown tantalum oxide film 11 and, therefore, the thus grown tantalum oxide film can be crystallized without much suffering from crack development therein during the subsequent recrystallization process.
- a crystalline tantalum oxide film having good step coverage is obtained by way of employing a two step process. That is, an amorphous tantalum oxide film 11 is formed first on the substrate 4 at a relatively low film growth temperature, e.g., near 440° C., by using, e.g., the CVD apparatus 50 shown in FIG. 5. Thereafter, a rapid thermal oxidation (RTO) process is carried out on the thus grown amorphous tantalum oxide film at about 650° C. to 800° C. in an O 2 atmosphere to obtain the crystalline tantalum oxide film with a good step coverage.
- RTO rapid thermal oxidation
- FIG. 8 depicts a relationship between the film growth temperature and the content of impurities, such as carbon and hydrogen, introduced in the tantalum oxide film 11 .
- impurities such as carbon and hydrogen
- a tantalum oxide film having a predetermined thickness by repeatedly forming a relatively thin amorphous tantalum oxide film and carrying out the RTO process thereon sequentially multiple times.
- RPO remote plasma oxidation
- FIG. 9 schematically shows a conventional substrate processing apparatus 90 capable of performing the CVD process, the RPO process and the RTO process described above.
- the substrate processing apparatus 90 is provided with a load lock chamber 21 , a substrate transfer chamber 25 , a CVD processing chamber (reaction chamber) 22 identical to that shown in FIG. 5, an RPO processing chamber 23 and an RTO processing chamber 24 .
- Arrows represent various substrate transfer paths.
- the substrate 4 is transferred from the load lock chamber 21 to the CVD processing chamber 22 in which the amorphous tantalum oxide film is formed on the substrate 4 . Thereafter, the substrate 4 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 22 to the RPO processing chamber 23 . In the RPO processing chamber 23 , the RPO process is carried out on the amorphous tantalum oxide film. The thus processed substrate 4 is then transferred from the RPO processing chamber 23 to the RTO processing chamber 24 . After carrying out the RTO process in the RTO processing chamber 24 , the substrate 4 is taken out from the substrate processing apparatus 90 via the load lock chamber 21 . By employing such a substrate processing apparatus 90 , a crystalline tantalum oxide film having a small amount of impurities such as carbon, hydrogen and the like can be formed on the substrate 4 .
- the amorphous tantalum oxide film formation and the RTO are carried out in a same reaction chamber, e.g., the processing chamber 1 of the CVD apparatus 50 shown in FIG. 5, the amorphous tantalum oxide formed outside the substrate 4 , e.g., on the wall of the processing chamber 1 or the shower head 5 , during the amorphous tantalum oxide film deposition process may also be crystallized by the RTO process and then thus crystallized tantalum oxide may be peeled off to fall down on the substrate 4 . Accordingly, the separate CVD and RTO processing chambers need be prepared as shown in FIG. 9.
- the substrate 4 need be repeatedly transferred between the CVD processing chamber and the RTO processing chamber and, therefore, the crystalline tantalum oxide film on the substrate 4 cannot be produced in an efficient manner.
- the substrate 4 also need be repeatedly transferred among the CVD processing chamber 22 , the RPO processing chamber 23 and the RTO processing chamber 24 , lowering the system efficiency and deteriorating the throughput of the substrate processing apparatus.
- a method for manufacturing a semiconductor device including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
- a method for processing a substrate including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
- an apparatus for processing a substrate including: a processing chamber for processing a substrate; a gas supply unit for providing a reactive gas into the processing chamber; a plasma generation unit; and a control unit, wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.
- FIG. 1 schematically illustrates a CVD apparatus in accordance with the present invention
- FIG. 2 depicts the relationship between the number of process cycles and the content of impurities included in an amorphous tantalum oxide film
- FIG. 3 presents the relationship between the number of process cycles and a leak current of a crystallized tantalum oxide film
- FIG. 4 schematically represents a substrate processing apparatus in accordance with the present invention
- FIG. 5 schematically shows a conventional CVD apparatus
- FIG. 6 sets forth a cross sectional view of a tantalum oxide film grown on a substrate
- FIG. 7 shows the relationship between the step coverage and the film growth temperature
- FIG. 8 depicts the relationship between the film growth temperature and the content of impurities included in a tantalum oxide film
- FIG. 9 schematically shows a conventional substrate processing apparatus.
- FIG. 1 schematically illustrates a CVD apparatus 10 in accordance with the present invention.
- a heater 32 is installed in a reactor chamber (hereinafter also referred to as a processing chamber) 31 .
- a substrate rotating unit 33 is installed outside the processing chamber 31 .
- a susceptor 34 rotated by the substrate rotating unit 33 is installed in the processing chamber 31 .
- the susceptor 34 is positioned on the heater 32 .
- a substrate 35 e.g., wafer
- a shower head 36 having shower holes 37 is installed above the susceptor 34 .
- a reactive gas supply unit 38 is installed outside the processing chamber 31 .
- a gas supply line 39 connects the reactive gas supply unit 38 to the shower head 36 and has a valve 40 .
- a reactive gas is supplied to the processing chamber 31 via shower holes 37 after passing through the gas supply line 39 and the shower head 36 .
- a RPO unit (plasma generating apparatus) 41 is installed outside the processing chamber 31 .
- a gas supply line 42 connects the RPO unit 41 with the shower head 36 and has a valve 43 .
- an exhaust line (exhaust port) 44 is installed at lower side wall of the processing chamber 31 .
- a control unit 45 is provided outside the processing chamber 31 .
- the control unit 45 serves to control the CVD apparatus 10 to repeatedly perform process cycles of a film forming process and a RPO process as many times as desired in the processing chamber 31 .
- an amorphous (non-crystalline) tantalum oxide film is grown on the substrate 35 and during the RPO process, specific elements such as carbon and hydrogen included in the thus grown amorphous tantalum oxide film are removed or reduced in their amount by the plasma process through the use of the RPO unit 41 .
- FIG. 1 there will be described a method for manufacturing a semiconductor device and processing a substrate by using the CVD apparatus 10 in accordance with the present invention.
- the substrate 35 is loaded on the susceptor. 34 positioned in the processing chamber 31 .
- the susceptor 34 is then rotated by the substrate rotating unit 33 and the substrate 35 is heated at about 440° C. by the heater 32 .
- the valve 40 is opened to supply the substrate 35 with a reactive gas containing the mixture of an evaporated PET, an oxygen gas and an inert gas via the gas supply line 39 and the shower head 36 , thereby forming an amorphous tantalum oxide film having a thickness of about 20 ⁇ grown on the substrate 35 (film growing process).
- valve 40 is closed to stop the reactive gas supply while maintaining the same condition in which the substrate 35 is rotated and heated at about 440° C.
- valve 43 is opened to introduce oxygen radicals generated from the RPO unit 41 on the substrate 35 though the gas supply line 42 and the shower head 36 to thereby carry out the RPO process on the thus grown amorphous tantalum oxide film (impurity removing process). Consequently, the film growing process and the impurity removing process are sequentially carried out in one processing chamber, i.e., the processing chamber 31 .
- both the film growing process and the impurity removing process are carried out at a substantially same temperature. That is to say, it is preferable that the setting temperature of the heater is maintained constant during the film growing process and the impurity removing process as well. By maintaining a constant temperature or greatly reducing a temperature variation in the processing chamber, particle generation due to thermal expansion of such parts as the shower head or the susceptor in the processing chamber can be suppressed and metal contamination originating from a metallic part in the processing chamber can also be prevented. In view of particulate generation discussed above, it is also preferable that both the film growing process and the impurity removing process are carried out at a constant pressure.
- An amorphous tantalum oxide film having a thickness of about 80 ⁇ can be formed by repeatedly performing four times the process cycle where one film forming process and one RPO process are carried out sequentially. That is, the film growing process and the impurity removing process are sequentially repeated a predetermined number of times by controlling the valves 40 , 43 through the use of the control unit 45 . Thereafter, the thus processed amorphous tantalum oxide film is treated to provide a crystalline tantalum oxide film by carrying out a RTO process thereon in a RTO process unit (not shown).
- the RPO process is carried out on the amorphous tantalum oxide film having a thickness of 20 ⁇ , i.e., a quarter of the final thickness of 80 ⁇ . Since such impurities as C and H can be removed or reduced more rapidly and uniformly from a thinner film by the RPO process, the amorphous tantalum oxide film having a predetermined final thickness with a low impurity content can be efficiently obtained by repeatedly performing the process cycles as described above.
- the amorphous tantalum oxide film is thin and therefore has a reduced amount of impurities, when the RPO process is performed on the amorphous tantalum oxide film having the thickness of 20 ⁇ , i.e., a quarter of the final thickness 80 ⁇ , less oxygen radicals are consumed at the entrance and the side wall of the groove, so that the sufficient amount of oxygen radicals can be uniformly supplied to the amorphous tantalum oxide film located at the bottom portion of the deep groove.
- the amorphous tantalum oxide film having a predetermined target thickness with a low impurity concentration of C, H and the like can be readily formed since the impurities can be uniformly removed in a short time.
- the amorphous tantalum oxide film is also formed on an inner wall of the processing chamber 31 and the shower head 36 . And as the film growing processes are repeated, the thickness of the accumulated film thereon becomes greater and so does the impurities such as C and H included in the accumulated film. As a result, more impurities are introduced in an amorphous tantalum oxide grown later, resulting in temporal variations in the amount of impurities contained in the amorphous tantalum oxide film formed on the substrate 35 .
- the impurities included in the thin film previously deposited outside the substrate can also be immediately removed by the subsequent RPO process. Resultantly, accumulation of the impurities in the ever thickening TaO film deposited inside the processing chamber can be effectively prevented and a content of the impurities included in the amorphous tantalum oxide film formed on the substrate 35 can be maintained rather uniformly, without suffering from temporal variations.
- an ALD (atomic layer deposition) scheme can be employed, in forming the amorphous tantalum film on the substrate.
- the ALD differs from the conventional CVD in that in ALD atomic layers are formed one at a time at a lower substrate treating temperature (300° C. or below) and under a low inner pressure inside the processing chamber (10 Pa or below) and further only a surface reaction (adsorption reaction) is taking place.
- the amorphous tantalum oxide film is formed by simultaneously growing tens of atomic layers, wherein the treating temperature of the substrate 35 is high (around 440° C.) and also the inner pressure of the processing chamber 31 is high (50 Pa or above) and further both the surface reaction and a vapor phase reaction are taking place.
- the film growing process and the impurities removing process are carried out with the substrate 35 being rotated, the film growth and the removal of the impurities can be uniformly accomplished throughout the substrate 35 . Therefore, both the amorphous and the crystalline tantalum oxide film with the uniform film quality and low impurity concentration can be formed on the substrate 35 . Also, it is possible to efficiently remove the impurities from the amorphous tantalum oxide film without incurring any damage thereon since the impurity removing process is carried out by using the RPO process.
- the crystallization process is carried out on the amorphous tantalum oxide film formed on the substrate 35 obtained by repeatedly performing the film forming process and the impurity removing process sequentially multiple times. Therefore, the crystalline tantalum oxide film having a good step coverage along with a low impurity concentration and good insulating properties can be efficiently formed on the substrate 35 . Further, the amorphous tantalum oxide film can be efficiently crystallized since the RTO process is employed in the crystallization process.
- FIG. 2 depicts a relationship between the number of process cycles and the total amount of impurities included in a crystalline tantalum oxide film, wherein in each process cycle one amorphous tantalum oxide film growing process and one RPO process have been sequentially carried out in the CVD apparatus described in FIG. 1. As shown in FIG. 2, the content of impurities included in the crystalline tantalum oxide film decreases as the number of process cycles increases.
- FIG. 3 presents a relationship between the number of process cycles and a leak current (A/cm 2 ) of a crystallized tantalum oxide film.
- the leak current of the crystalline tantalum oxide film decreases as shown in FIG. 3 and the insulating properties thereof become improved as the number of process cycles increases.
- FIG. 4 there is illustrated a substrate processing apparatus 40 in accordance with the present invention, including a load lock chamber 51 , a substrate transfer chamber 55 , CVD processing chambers 52 and 53 identical to that described in FIG. 1 and a RTO processing chamber 54 . Arrows represent various substrate transfer paths.
- the substrate 35 is transferred from the load lock chamber 51 to the CVD processing chamber 52 or 53 , wherein the amorphous tantalum oxide film is formed on the substrate 35 by repeating the amorphous tantalum oxide film growing process and the RPO process sequentially a number of times. Thereafter, the substrate 35 having the amorphous tantalum oxide film thereon is transferred from the CVD processing chamber 52 or 53 to the RTO processing chamber 54 . After carrying out the RTO process in the RTO processing chamber 54 , the substrate 35 is taken out from the substrate processing apparatus 50 via the load lock chamber 51 .
- the amorphous tantalum oxide film having a low impurity content of C, H and the like is formed on the substrate 35 by repeatedly performing the process cycles, in which the amorphous tantalum oxide film forming process and the RPO process are sequentially carried out multiple times. Further, the number of transfer processes per each substrate is three in the preferred substrate processing apparatus 40 shown in FIG. 4, while same is four in the conventional substrate processing apparatus 90 shown in FIG. 9. Therefore, the system efficiency and the throughput of product in accordance with the present invention can be improved, in comparison with the prior art substrate processing apparatus.
- the present invention can also be applied in cases where other types of films are formed on a substrate by using other types of source materials.
- the present invention can be advantageously applied to the case where an organic material is used as the source material of a film since the amount of impurities introduced in the grown film becomes large by the use of the organic material.
Abstract
A substrate processing apparatus includes a CVD (chemical vapor deposition) processing chamber and a RTO (rapid thermal oxidation) processing chamber. In the CVD processing chamber, a film growing process, in which thin amorphous film is deposited on a substrate, and an impurity removing process, in which specific impurities included in the grown amorphous film are removed, are repeatedly performed multiple times to provide an impurity removed amorphous film with good step coverage. Thus treated amorphous film on the substrate is then crystallized in the RTO process chamber to provide a crystalline film.
Description
- The present invention relates to a method and apparatus for manufacturing a semiconductor device and processing a substrate.
- FIG. 5 shows a schematic view of a conventional chemical vapor deposition (CVD)
apparatus 50 for use in processing a substrate. As shown in FIG. 5, theapparatus 50 includes aheater 2 installed in a reactor chamber (hereinafter also referred to as a processing chamber) 1, asusceptor 3 positioned above theheater 2, ashower head 5 havingshower holes 6 and installed above thesusceptor 3, a gas inlet 7 jointed above theshower head 5, and anexhaust port 8 provided at theprocessing chamber 1. - In the
apparatus 50, asubstrate 4 is mounted on thesusceptor 3 positioned in the hermetically sealedprocessing chamber 1 and is heated by theheater 2. In the meantime, a reactive gas obtained by mixing an evaporated Penta Ethoxy Tantalum (Ta(OC2H5)5, hereinafter referred to as PET), an oxygen gas and an inert gas is supplied to thesubstrate 4 after passing through the gas inlet 7 and theshower head 5. A tantalum oxide film is then formed on minute electrical circuit patterns positioned on thesubstrate 4 by the chemical reaction of the reactive gas that takes place on thesubstrate 4. Also, an exhausted gas is pumped out from theprocessing chamber 1 via theexhaust port 8. - Referring to FIG. 6, there is illustrated a
tantalum oxide film 11 grown on thesubstrate 4 with a step coverage (b/a), a and b representing a film thickness on the top surface of thesubstrate 4 and that on the bottom of a recess of thesubstrate 4, respectively. FIG. 7 shows the relationship between a step coverage (b/a) and the substrate temperature during the film growth (referred to as film growth temperature hereinafter). - In case the film growth temperature is low, the step coverage of the
tantalum oxide film 11 is good as shown in FIG. 7 and thetantalum oxide film 11 becomes an amorphous tantalum oxide film (TaO film). On the other hand, when the film growth temperature is high, the step coverage of thetantalum oxide film 11 is poor and thetantalum oxide film 11 becomes a crystalline tantalum oxide film (Ta2O5 film). Also, if the film growth temperature is low, e.g., around 440° C., no significant stress is induced in the growntantalum oxide film 11 and, therefore, the thus grown tantalum oxide film can be crystallized without much suffering from crack development therein during the subsequent recrystallization process. - For this reason, a crystalline tantalum oxide film having good step coverage is obtained by way of employing a two step process. That is, an amorphous
tantalum oxide film 11 is formed first on thesubstrate 4 at a relatively low film growth temperature, e.g., near 440° C., by using, e.g., theCVD apparatus 50 shown in FIG. 5. Thereafter, a rapid thermal oxidation (RTO) process is carried out on the thus grown amorphous tantalum oxide film at about 650° C. to 800° C. in an O2 atmosphere to obtain the crystalline tantalum oxide film with a good step coverage. - FIG. 8 depicts a relationship between the film growth temperature and the content of impurities, such as carbon and hydrogen, introduced in the
tantalum oxide film 11. In case where the film growth temperature is low, the growingtantalum oxide film 11 becomes amorphous and the content of impurities, such as carbon, hydrogen and the like introduced therein during the growth, increases. - In other words, when the amorphous tantalum oxide film is formed on the
substrate 4, a large amount of impurities such as carbon, hydrogen and the like originated from the organic source material, e.g., PET, is introduced into the growing amorphous tantalum oxide film. Therefore, it may be necessary to remove the thus introduced impurities simultaneously during the RTO process described above. - Since, however, the crystallization of the amorphous tantalum oxide film carried out by the RTO process is initiated at the surface of the amorphous tantalum oxide film and progresses into the inner portion thereof, the impurities such as carbon, hydrogen and the like may not be effectively removed from the film. In other words, as the amorphous tantalum oxide film becomes crystallized, a mean distance between atoms constituting the film gets reduced and further voids or vacancies among the atoms constituting the film also diminishes. Accordingly, impurity atoms included inside the film cannot readily pass through the atoms of the crystallized tantalum oxide film formed at the surface region. As a result, it becomes difficult to remove the impurities remaining inside the tantalum oxide film once the crystallization takes place at the surface region thereof and, therefore, insulation properties of the crystallized tantalum oxide film are deteriorated.
- Therefore, it may be preferable to form a tantalum oxide film having a predetermined thickness, by repeatedly forming a relatively thin amorphous tantalum oxide film and carrying out the RTO process thereon sequentially multiple times.
- Further, it may be more preferable to subject the amorphous tantalum oxide film grown in the
CVD apparatus 50 shown in FIG. 5 to a remote plasma oxidation (RPO) process to remove the impurities included in the film by oxygen radicals, followed by the RTO process described above. - FIG. 9 schematically shows a conventional
substrate processing apparatus 90 capable of performing the CVD process, the RPO process and the RTO process described above. As shown in FIG. 9, thesubstrate processing apparatus 90 is provided with aload lock chamber 21, asubstrate transfer chamber 25, a CVD processing chamber (reaction chamber) 22 identical to that shown in FIG. 5, anRPO processing chamber 23 and anRTO processing chamber 24. Arrows represent various substrate transfer paths. - In the
substrate processing apparatus 90, thesubstrate 4 is transferred from theload lock chamber 21 to theCVD processing chamber 22 in which the amorphous tantalum oxide film is formed on thesubstrate 4. Thereafter, thesubstrate 4 having the amorphous tantalum oxide film thereon is transferred from theCVD processing chamber 22 to theRPO processing chamber 23. In theRPO processing chamber 23, the RPO process is carried out on the amorphous tantalum oxide film. The thus processedsubstrate 4 is then transferred from theRPO processing chamber 23 to theRTO processing chamber 24. After carrying out the RTO process in theRTO processing chamber 24, thesubstrate 4 is taken out from thesubstrate processing apparatus 90 via theload lock chamber 21. By employing such asubstrate processing apparatus 90, a crystalline tantalum oxide film having a small amount of impurities such as carbon, hydrogen and the like can be formed on thesubstrate 4. - In case the amorphous tantalum oxide film formation and the RTO are carried out in a same reaction chamber, e.g., the
processing chamber 1 of theCVD apparatus 50 shown in FIG. 5, the amorphous tantalum oxide formed outside thesubstrate 4, e.g., on the wall of theprocessing chamber 1 or theshower head 5, during the amorphous tantalum oxide film deposition process may also be crystallized by the RTO process and then thus crystallized tantalum oxide may be peeled off to fall down on thesubstrate 4. Accordingly, the separate CVD and RTO processing chambers need be prepared as shown in FIG. 9. - Therefore, in case where a crystalline tantalum oxide film is formed by repeatedly performing the amorphous tantalum oxide film deposition process and the RTO process sequentially, the
substrate 4 need be repeatedly transferred between the CVD processing chamber and the RTO processing chamber and, therefore, the crystalline tantalum oxide film on thesubstrate 4 cannot be produced in an efficient manner. - Similarly, in the
substrate processing apparatus 90, thesubstrate 4 also need be repeatedly transferred among theCVD processing chamber 22, theRPO processing chamber 23 and theRTO processing chamber 24, lowering the system efficiency and deteriorating the throughput of the substrate processing apparatus. - It is, therefore, an object of the present invention to provide a method and apparatus for manufacturing a semiconductor device and processing a substrate, capable of efficiently forming a film having low content of such impurities as carbon, hydrogen and the like on a substrate.
- In accordance with one aspect of the invention, there is provided a method for manufacturing a semiconductor device, including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
- In accordance with another aspect of the invention, there is provided a method for processing a substrate, including the steps of: (a) forming an amorphous film on a substrate; (b) removing at least a portion of an impurity element included in the amorphous film; and (c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
- In accordance with still another aspect of the invention, there is provided an apparatus for processing a substrate, including: a processing chamber for processing a substrate; a gas supply unit for providing a reactive gas into the processing chamber; a plasma generation unit; and a control unit, wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.
- The above and other objects and features of the present invention will become apparent from the following description given in conjunction with the accompanying drawings, in which:
- FIG. 1 schematically illustrates a CVD apparatus in accordance with the present invention;
- FIG. 2 depicts the relationship between the number of process cycles and the content of impurities included in an amorphous tantalum oxide film;
- FIG. 3 presents the relationship between the number of process cycles and a leak current of a crystallized tantalum oxide film;
- FIG. 4 schematically represents a substrate processing apparatus in accordance with the present invention;
- FIG. 5 schematically shows a conventional CVD apparatus;
- FIG. 6 sets forth a cross sectional view of a tantalum oxide film grown on a substrate;
- FIG. 7 shows the relationship between the step coverage and the film growth temperature;
- FIG. 8 depicts the relationship between the film growth temperature and the content of impurities included in a tantalum oxide film; and
- FIG. 9 schematically shows a conventional substrate processing apparatus.
- FIG. 1 schematically illustrates a
CVD apparatus 10 in accordance with the present invention. As shown in FIG. 1, aheater 32 is installed in a reactor chamber (hereinafter also referred to as a processing chamber) 31. Asubstrate rotating unit 33 is installed outside theprocessing chamber 31. Asusceptor 34 rotated by thesubstrate rotating unit 33 is installed in theprocessing chamber 31. Thesusceptor 34 is positioned on theheater 32. - Further, a
substrate 35, e.g., wafer, is loaded on thesusceptor 34. Ashower head 36 havingshower holes 37 is installed above thesusceptor 34. A reactivegas supply unit 38 is installed outside theprocessing chamber 31. Agas supply line 39 connects the reactivegas supply unit 38 to theshower head 36 and has avalve 40. A reactive gas is supplied to theprocessing chamber 31 via shower holes 37 after passing through thegas supply line 39 and theshower head 36. - Further, a RPO unit (plasma generating apparatus)41 is installed outside the
processing chamber 31. Agas supply line 42 connects theRPO unit 41 with theshower head 36 and has avalve 43. Also, an exhaust line (exhaust port) 44 is installed at lower side wall of theprocessing chamber 31. - Additionally, a
control unit 45 is provided outside theprocessing chamber 31. Thecontrol unit 45 serves to control theCVD apparatus 10 to repeatedly perform process cycles of a film forming process and a RPO process as many times as desired in theprocessing chamber 31. During the film forming process, an amorphous (non-crystalline) tantalum oxide film is grown on thesubstrate 35 and during the RPO process, specific elements such as carbon and hydrogen included in the thus grown amorphous tantalum oxide film are removed or reduced in their amount by the plasma process through the use of theRPO unit 41. - Referring to FIG. 1, there will be described a method for manufacturing a semiconductor device and processing a substrate by using the
CVD apparatus 10 in accordance with the present invention. First, thesubstrate 35 is loaded on the susceptor. 34 positioned in theprocessing chamber 31. Thesusceptor 34 is then rotated by thesubstrate rotating unit 33 and thesubstrate 35 is heated at about 440° C. by theheater 32. While thesubstrate 35 is rotated and heated at about 440° C., thevalve 40 is opened to supply thesubstrate 35 with a reactive gas containing the mixture of an evaporated PET, an oxygen gas and an inert gas via thegas supply line 39 and theshower head 36, thereby forming an amorphous tantalum oxide film having a thickness of about 20 Å grown on the substrate 35 (film growing process). - Subsequently, the
valve 40 is closed to stop the reactive gas supply while maintaining the same condition in which thesubstrate 35 is rotated and heated at about 440° C. Thereafter, thevalve 43 is opened to introduce oxygen radicals generated from theRPO unit 41 on thesubstrate 35 though thegas supply line 42 and theshower head 36 to thereby carry out the RPO process on the thus grown amorphous tantalum oxide film (impurity removing process). Consequently, the film growing process and the impurity removing process are sequentially carried out in one processing chamber, i.e., theprocessing chamber 31. - Further, it is preferable that both the film growing process and the impurity removing process are carried out at a substantially same temperature. That is to say, it is preferable that the setting temperature of the heater is maintained constant during the film growing process and the impurity removing process as well. By maintaining a constant temperature or greatly reducing a temperature variation in the processing chamber, particle generation due to thermal expansion of such parts as the shower head or the susceptor in the processing chamber can be suppressed and metal contamination originating from a metallic part in the processing chamber can also be prevented. In view of particulate generation discussed above, it is also preferable that both the film growing process and the impurity removing process are carried out at a constant pressure.
- An amorphous tantalum oxide film having a thickness of about 80 Å can be formed by repeatedly performing four times the process cycle where one film forming process and one RPO process are carried out sequentially. That is, the film growing process and the impurity removing process are sequentially repeated a predetermined number of times by controlling the
valves control unit 45. Thereafter, the thus processed amorphous tantalum oxide film is treated to provide a crystalline tantalum oxide film by carrying out a RTO process thereon in a RTO process unit (not shown). - In the method and apparatus for manufacturing the semiconductor device and processing the substrate, the RPO process is carried out on the amorphous tantalum oxide film having a thickness of 20 Å, i.e., a quarter of the final thickness of 80 Å. Since such impurities as C and H can be removed or reduced more rapidly and uniformly from a thinner film by the RPO process, the amorphous tantalum oxide film having a predetermined final thickness with a low impurity content can be efficiently obtained by repeatedly performing the process cycles as described above.
- Some of the advantages obtainable by repeatedly performing the film growing process and the impurity removing process will now be described. In case a thick amorphous tantalum oxide film having a thickness of, e.g., 80 Å with a good step coverage is formed on a substrate having a deep recess or groove, a large amount of impurities is included in the film due to its large thickness. Therefore, if the RPO process is carried out thereon, a possibility that the oxygen radicals are consumed by the reaction with the impurities included in the amorphous tantalum oxide film located at the entrance and the side wall of the deep groove is increased. Accordingly, the impurities such as C and H cannot be uniformly removed in a short time since sufficient oxygen radicals may not be provided to the amorphous tantalum oxide film formed at the bottom of the deep groove.
- On the other hand, since the amorphous tantalum oxide film is thin and therefore has a reduced amount of impurities, when the RPO process is performed on the amorphous tantalum oxide film having the thickness of 20 Å, i.e., a quarter of the final thickness 80 Å, less oxygen radicals are consumed at the entrance and the side wall of the groove, so that the sufficient amount of oxygen radicals can be uniformly supplied to the amorphous tantalum oxide film located at the bottom portion of the deep groove. As a result, the amorphous tantalum oxide film having a predetermined target thickness with a low impurity concentration of C, H and the like can be readily formed since the impurities can be uniformly removed in a short time.
- During the film growing process, the amorphous tantalum oxide film is also formed on an inner wall of the
processing chamber 31 and theshower head 36. And as the film growing processes are repeated, the thickness of the accumulated film thereon becomes greater and so does the impurities such as C and H included in the accumulated film. As a result, more impurities are introduced in an amorphous tantalum oxide grown later, resulting in temporal variations in the amount of impurities contained in the amorphous tantalum oxide film formed on thesubstrate 35. - In contrast, since the growing process and the RPO process are carried out in a cyclic manner in the same processing chamber in accordance with the present invention, the impurities included in the thin film previously deposited outside the substrate can also be immediately removed by the subsequent RPO process. Resultantly, accumulation of the impurities in the ever thickening TaO film deposited inside the processing chamber can be effectively prevented and a content of the impurities included in the amorphous tantalum oxide film formed on the
substrate 35 can be maintained rather uniformly, without suffering from temporal variations. - Instead of the CVD technique disclosed above, an ALD (atomic layer deposition) scheme can be employed, in forming the amorphous tantalum film on the substrate. The ALD differs from the conventional CVD in that in ALD atomic layers are formed one at a time at a lower substrate treating temperature (300° C. or below) and under a low inner pressure inside the processing chamber (10 Pa or below) and further only a surface reaction (adsorption reaction) is taking place. On the other hand, in the method and apparatus for manufacturing a semiconductor device and processing a substrate described above, the amorphous tantalum oxide film is formed by simultaneously growing tens of atomic layers, wherein the treating temperature of the
substrate 35 is high (around 440° C.) and also the inner pressure of theprocessing chamber 31 is high (50 Pa or above) and further both the surface reaction and a vapor phase reaction are taking place. Further, since the film growing process and the impurities removing process are carried out with thesubstrate 35 being rotated, the film growth and the removal of the impurities can be uniformly accomplished throughout thesubstrate 35. Therefore, both the amorphous and the crystalline tantalum oxide film with the uniform film quality and low impurity concentration can be formed on thesubstrate 35. Also, it is possible to efficiently remove the impurities from the amorphous tantalum oxide film without incurring any damage thereon since the impurity removing process is carried out by using the RPO process. - Further, the crystallization process is carried out on the amorphous tantalum oxide film formed on the
substrate 35 obtained by repeatedly performing the film forming process and the impurity removing process sequentially multiple times. Therefore, the crystalline tantalum oxide film having a good step coverage along with a low impurity concentration and good insulating properties can be efficiently formed on thesubstrate 35. Further, the amorphous tantalum oxide film can be efficiently crystallized since the RTO process is employed in the crystallization process. - FIG. 2 depicts a relationship between the number of process cycles and the total amount of impurities included in a crystalline tantalum oxide film, wherein in each process cycle one amorphous tantalum oxide film growing process and one RPO process have been sequentially carried out in the CVD apparatus described in FIG. 1. As shown in FIG. 2, the content of impurities included in the crystalline tantalum oxide film decreases as the number of process cycles increases.
- FIG. 3 presents a relationship between the number of process cycles and a leak current (A/cm2) of a crystallized tantalum oxide film. The leak current of the crystalline tantalum oxide film decreases as shown in FIG. 3 and the insulating properties thereof become improved as the number of process cycles increases.
- Referring to FIG. 4, there is illustrated a
substrate processing apparatus 40 in accordance with the present invention, including aload lock chamber 51, asubstrate transfer chamber 55,CVD processing chambers RTO processing chamber 54. Arrows represent various substrate transfer paths. - In the
substrate processing apparatus 40, thesubstrate 35 is transferred from theload lock chamber 51 to theCVD processing chamber substrate 35 by repeating the amorphous tantalum oxide film growing process and the RPO process sequentially a number of times. Thereafter, thesubstrate 35 having the amorphous tantalum oxide film thereon is transferred from theCVD processing chamber RTO processing chamber 54. After carrying out the RTO process in theRTO processing chamber 54, thesubstrate 35 is taken out from thesubstrate processing apparatus 50 via theload lock chamber 51. - In such a
substrate processing apparatus 40, the amorphous tantalum oxide film having a low impurity content of C, H and the like is formed on thesubstrate 35 by repeatedly performing the process cycles, in which the amorphous tantalum oxide film forming process and the RPO process are sequentially carried out multiple times. Further, the number of transfer processes per each substrate is three in the preferredsubstrate processing apparatus 40 shown in FIG. 4, while same is four in the conventionalsubstrate processing apparatus 90 shown in FIG. 9. Therefore, the system efficiency and the throughput of product in accordance with the present invention can be improved, in comparison with the prior art substrate processing apparatus. Although the preferred embodiment of the present invention has been described with respect to the tantalum oxide film formed on thesubstrate 35 by using an organic liquid material, e.g., PET, the present invention can also be applied in cases where other types of films are formed on a substrate by using other types of source materials. - The present invention can be advantageously applied to the case where an organic material is used as the source material of a film since the amount of impurities introduced in the grown film becomes large by the use of the organic material.
- Further, it is to be appreciated that other plasma process than the RPO process described above can also be employed in the impurity removing process.
- Also, other crystallization process than the RTO process described in the preferred embodiment of the invention can also be equally employed in the crystallization process of the film.
- While the present invention has been described with respect to certain preferred embodiments only, other modifications and variations may be made without departing from the sprit and scope of the present invention as set forth in the following claims.
Claims (10)
1. A method for manufacturing a semiconductor device, comprising the steps of:
(a) forming an amorphous film on a substrate;
(b) removing at least a portion of an impurity element included in the amorphous film; and
(c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
2. The method of claim 1 , wherein the forming step (a) and the removing step (b) are carried out in a same reaction chamber.
3. The method of claim 2 , wherein the forming step (a) and the removing step (b) are carried out at the same temperature.
4. The method of claim 1 , wherein the removing step (b) is carried out while rotating the substrate.
5. The method of claim 1 , wherein the amorphous film is an amorphous tantalum oxide film.
6. The method of claim 1 , wherein the removing step (b) is carried out by a plasma process.
7. The method of claim 1 , further comprising, after the step (c), the step (d) of performing a crystallization process to crystallize the non-crystalline film formed on the substrate.
8. The method of claim 7 , wherein the crystallization process is a rapid thermal oxidation process.
9. A method for processing a substrate, comprising the steps of:
(a) forming an amorphous film on a substrate;
(b) removing at least a portion of an impurity element included in the amorphous film; and
(c) sequentially repeating the forming step (a) and the removing step (b) multiple times to provide an impurity removed non-crystalline film on the substrate.
10. A substrate processing apparatus, comprising:
a processing chamber for processing a substrate;
a gas supply unit for providing a reactive gas into the processing chamber;
a plasma generation unit; and
a control unit,
wherein the control unit controls the substrate processing apparatus to sequentially repeat, in the processing chamber, a film forming process for depositing an amorphous film on the substrate through the use of the reactive gas and a plasma process for removing at least a portion of an impurity element included in the amorphous film through the use of the plasma generation unit.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001187468A JP2003007697A (en) | 2001-06-21 | 2001-06-21 | Method for manufacturing semiconductor device, method and apparatus for processing substrate |
JP2001-187468 | 2001-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020197828A1 true US20020197828A1 (en) | 2002-12-26 |
Family
ID=19026751
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/106,234 Abandoned US20020197828A1 (en) | 2001-06-21 | 2002-03-27 | Method and apparatus for manufacturing a semiconductor device and processing a substrate |
US10/109,216 Expired - Lifetime US6687050B2 (en) | 2001-06-21 | 2002-03-28 | Amplifier gain error |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/109,216 Expired - Lifetime US6687050B2 (en) | 2001-06-21 | 2002-03-28 | Amplifier gain error |
Country Status (4)
Country | Link |
---|---|
US (2) | US20020197828A1 (en) |
JP (1) | JP2003007697A (en) |
KR (1) | KR20020096860A (en) |
TW (1) | TW577123B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040191426A1 (en) * | 2003-03-26 | 2004-09-30 | Anelva Corporation | Film-forming method for forming metal oxide on substrate surface |
US20130078789A1 (en) * | 2011-09-22 | 2013-03-28 | Hitachi Kokusai Electric Inc. | Substrate Processing Apparatus, Method of Manufacturing Semiconductor Device and Non-Transitory Computer-Readable Recording Medium |
CN104233227A (en) * | 2014-09-23 | 2014-12-24 | 上海华力微电子有限公司 | Atomic layer deposition equipment and method |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6917731B2 (en) * | 2002-03-27 | 2005-07-12 | Corning Incorporated | Optical amplification module |
JP4911984B2 (en) * | 2006-02-08 | 2012-04-04 | 東京エレクトロン株式会社 | Gas supply apparatus, substrate processing apparatus, gas supply method, and shower head |
Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034394A (en) * | 1988-06-27 | 1991-07-23 | Burroughs Wellcome Co. | Therapeutic nucleosides |
US5232928A (en) * | 1989-07-25 | 1993-08-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tetrahydroisoquinoline amides |
US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US20030236242A1 (en) * | 2000-04-03 | 2003-12-25 | Robert Perni | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
US20040229848A1 (en) * | 2003-05-05 | 2004-11-18 | Hans-Ulrich Demuth | Glutaminyl based DP IV-inhibitors |
US20040259804A1 (en) * | 1998-10-22 | 2004-12-23 | Karanewsky Donald S. | (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
US6867303B2 (en) * | 2002-10-15 | 2005-03-15 | Boehringer Ingelheim International Gmbh | Ruthenium complexes as (pre)catalysts for metathesis reactions |
US20050119189A1 (en) * | 2003-09-18 | 2005-06-02 | Cottrell Kevin M. | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US20050192212A1 (en) * | 2004-01-21 | 2005-09-01 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
US20050197301A1 (en) * | 2004-02-27 | 2005-09-08 | Schering Corporation | 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
US20050209135A1 (en) * | 2004-03-15 | 2005-09-22 | Boehringer Ingelheim International Gmbh | Process for preparing macrocyclic compounds |
US20050215513A1 (en) * | 2003-04-25 | 2005-09-29 | Boojamra Constantine G | Antiviral phosphonate analogs |
US20050267151A1 (en) * | 2004-05-25 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Process for preparing acyclic HCV protease inhibitors |
US20060019905A1 (en) * | 2004-07-20 | 2006-01-26 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor peptide analogs |
US20060063915A1 (en) * | 2004-09-17 | 2006-03-23 | Boehringer Ingelheim International Gmbh | Ring-closing metathesis process in supercritical fluid |
US20060069099A1 (en) * | 2004-06-28 | 2006-03-30 | Zice Fu | Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
US20060198824A1 (en) * | 2005-03-02 | 2006-09-07 | Schering Corporation | Treatments for flaviviridae virus infection |
US20060269516A1 (en) * | 2005-05-26 | 2006-11-30 | Schering Corporation | Interferon-IgG fusion |
US20060276405A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methods for treating hepatitis C |
US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
US20070010455A1 (en) * | 2005-07-11 | 2007-01-11 | Piyasena Hewawasam | Hepatitis C virus inhibitors |
US20070027071A1 (en) * | 2005-07-20 | 2007-02-01 | Holloway M K | HCV NS3 protease inhibitors |
US20070032433A1 (en) * | 2000-07-21 | 2007-02-08 | Schering Corporation Corvas International, Ltd. | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
US20070054842A1 (en) * | 2005-07-25 | 2007-03-08 | Blatt Lawrence M | Novel macrocyclic inhibitors of hepatitis C virus replication |
US20070054864A1 (en) * | 2005-06-30 | 2007-03-08 | Michael Graupe | HCV Inhibitors |
US20070072809A1 (en) * | 2005-07-14 | 2007-03-29 | Gilead Sciences, Inc. | Antiviral compounds |
US7273851B2 (en) * | 2003-06-05 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | Tri-peptide hepatitis C serine protease inhibitors |
US20070299078A1 (en) * | 2006-06-26 | 2007-12-27 | Deqiang Niu | Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors |
US20080014173A1 (en) * | 2006-07-11 | 2008-01-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20080107623A1 (en) * | 2006-11-01 | 2008-05-08 | Bristol-Myers Squibb Company | Inhibitors of Hepatitis C Virus |
US7378422B2 (en) * | 2003-09-05 | 2008-05-27 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US20080125444A1 (en) * | 2006-06-06 | 2008-05-29 | Ying Sun | Acyclic oximyl hepatitis c protease inhibitors |
US7399749B2 (en) * | 2004-05-20 | 2008-07-15 | Schering Corporation | Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease |
US7449591B2 (en) * | 2004-01-28 | 2008-11-11 | Boehringer Ingelheim International Gmbh | Process of removing transition metals |
US7482501B2 (en) * | 2005-01-17 | 2009-01-27 | Boehringer Ingelheim International Gmbh | Process for continuous ringclosing metathesis in compressed carbondioxide |
US7491794B2 (en) * | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
US20090048297A1 (en) * | 2006-07-13 | 2009-02-19 | Achillion Pharmaceuticals | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
US7494660B2 (en) * | 2003-10-27 | 2009-02-24 | Vertex Pharmaceuticals Incorporated | HCV NS3-NS4A protease resistance mutants |
US20090075869A1 (en) * | 2005-05-02 | 2009-03-19 | Holloway M Katharine | HCV NS3 protease inhibitors |
US20090093533A1 (en) * | 2005-10-11 | 2009-04-09 | Leonid Beigelman | Compounds and methods for inhibiting hepatitis c viral replication |
US20090155209A1 (en) * | 2007-05-03 | 2009-06-18 | Blatt Lawrence M | Novel macrocyclic inhibitors of hepatitis c virus replication |
US20090203008A1 (en) * | 2006-06-08 | 2009-08-13 | Ludmerer Steven W | Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples |
US20090269305A1 (en) * | 2008-04-15 | 2009-10-29 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
US20090297476A1 (en) * | 2007-05-10 | 2009-12-03 | Intermune, Inc. | Novel peptide inhibitors of hepatitis c virus replication |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09321701A (en) * | 1996-05-31 | 1997-12-12 | Fujitsu Ltd | Optical communication system and optical amplifier |
KR100292218B1 (en) * | 1997-11-25 | 2001-07-12 | 황 철 주 | Method of fabricating semiconductor device |
JP4005646B2 (en) * | 1998-02-06 | 2007-11-07 | 富士通株式会社 | Optical amplifier and excitation light source control method in optical amplifier |
KR100324718B1 (en) * | 1998-06-10 | 2002-02-28 | 황 철 주 | Method for fabricating semiconductor devices |
KR100338815B1 (en) * | 1999-10-05 | 2002-05-31 | 박종섭 | Method For Forming The Tantalum Oxide Layer Capacitor |
KR100390831B1 (en) * | 2000-12-18 | 2003-07-10 | 주식회사 하이닉스반도체 | Method for forming Ta2O5 dielectric layer by Plasma Enhanced Atomic Layer Deposition |
-
2001
- 2001-06-21 JP JP2001187468A patent/JP2003007697A/en active Pending
-
2002
- 2002-03-22 KR KR1020020015531A patent/KR20020096860A/en active IP Right Grant
- 2002-03-27 TW TW091106064A patent/TW577123B/en active
- 2002-03-27 US US10/106,234 patent/US20020197828A1/en not_active Abandoned
- 2002-03-28 US US10/109,216 patent/US6687050B2/en not_active Expired - Lifetime
Patent Citations (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034394A (en) * | 1988-06-27 | 1991-07-23 | Burroughs Wellcome Co. | Therapeutic nucleosides |
US5232928A (en) * | 1989-07-25 | 1993-08-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tetrahydroisoquinoline amides |
US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US20040259804A1 (en) * | 1998-10-22 | 2004-12-23 | Karanewsky Donald S. | (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
US20030236242A1 (en) * | 2000-04-03 | 2003-12-25 | Robert Perni | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
US20070032433A1 (en) * | 2000-07-21 | 2007-02-08 | Schering Corporation Corvas International, Ltd. | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
US6867303B2 (en) * | 2002-10-15 | 2005-03-15 | Boehringer Ingelheim International Gmbh | Ruthenium complexes as (pre)catalysts for metathesis reactions |
US20050215513A1 (en) * | 2003-04-25 | 2005-09-29 | Boojamra Constantine G | Antiviral phosphonate analogs |
US20040229848A1 (en) * | 2003-05-05 | 2004-11-18 | Hans-Ulrich Demuth | Glutaminyl based DP IV-inhibitors |
US7273851B2 (en) * | 2003-06-05 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | Tri-peptide hepatitis C serine protease inhibitors |
US7378422B2 (en) * | 2003-09-05 | 2008-05-27 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US20050119189A1 (en) * | 2003-09-18 | 2005-06-02 | Cottrell Kevin M. | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US7491794B2 (en) * | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
US20090286843A1 (en) * | 2003-10-14 | 2009-11-19 | Blatt Lawrence M | Macrocyclic compounds as inhibitors of viral replication |
US20090105471A1 (en) * | 2003-10-14 | 2009-04-23 | Blatt Lawrence M | Macrocyclic compounds as inhibitors of viral replication |
US20090111982A1 (en) * | 2003-10-14 | 2009-04-30 | Blatt Lawrence M | Macrocyclic compounds as inhibitors of viral replication |
US20090111969A1 (en) * | 2003-10-14 | 2009-04-30 | Blatt Lawrence M | Macrocyclic compounds as inhibitors of viral replication |
US7494660B2 (en) * | 2003-10-27 | 2009-02-24 | Vertex Pharmaceuticals Incorporated | HCV NS3-NS4A protease resistance mutants |
US20050192212A1 (en) * | 2004-01-21 | 2005-09-01 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
US7449591B2 (en) * | 2004-01-28 | 2008-11-11 | Boehringer Ingelheim International Gmbh | Process of removing transition metals |
US20050197301A1 (en) * | 2004-02-27 | 2005-09-08 | Schering Corporation | 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
US20050209135A1 (en) * | 2004-03-15 | 2005-09-22 | Boehringer Ingelheim International Gmbh | Process for preparing macrocyclic compounds |
US7399749B2 (en) * | 2004-05-20 | 2008-07-15 | Schering Corporation | Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease |
US20050267151A1 (en) * | 2004-05-25 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Process for preparing acyclic HCV protease inhibitors |
US20060069099A1 (en) * | 2004-06-28 | 2006-03-30 | Zice Fu | Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
US20060019905A1 (en) * | 2004-07-20 | 2006-01-26 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor peptide analogs |
US20060063915A1 (en) * | 2004-09-17 | 2006-03-23 | Boehringer Ingelheim International Gmbh | Ring-closing metathesis process in supercritical fluid |
US7482501B2 (en) * | 2005-01-17 | 2009-01-27 | Boehringer Ingelheim International Gmbh | Process for continuous ringclosing metathesis in compressed carbondioxide |
US20060198824A1 (en) * | 2005-03-02 | 2006-09-07 | Schering Corporation | Treatments for flaviviridae virus infection |
US20090075869A1 (en) * | 2005-05-02 | 2009-03-19 | Holloway M Katharine | HCV NS3 protease inhibitors |
US20060269516A1 (en) * | 2005-05-26 | 2006-11-30 | Schering Corporation | Interferon-IgG fusion |
US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
US20060276405A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methods for treating hepatitis C |
US20070054864A1 (en) * | 2005-06-30 | 2007-03-08 | Michael Graupe | HCV Inhibitors |
US20070010455A1 (en) * | 2005-07-11 | 2007-01-11 | Piyasena Hewawasam | Hepatitis C virus inhibitors |
US20070072809A1 (en) * | 2005-07-14 | 2007-03-29 | Gilead Sciences, Inc. | Antiviral compounds |
US20070027071A1 (en) * | 2005-07-20 | 2007-02-01 | Holloway M K | HCV NS3 protease inhibitors |
US20090148407A1 (en) * | 2005-07-25 | 2009-06-11 | Intermune, Inc. | Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication |
US20070054842A1 (en) * | 2005-07-25 | 2007-03-08 | Blatt Lawrence M | Novel macrocyclic inhibitors of hepatitis C virus replication |
US20090093533A1 (en) * | 2005-10-11 | 2009-04-09 | Leonid Beigelman | Compounds and methods for inhibiting hepatitis c viral replication |
US20080125444A1 (en) * | 2006-06-06 | 2008-05-29 | Ying Sun | Acyclic oximyl hepatitis c protease inhibitors |
US20090203008A1 (en) * | 2006-06-08 | 2009-08-13 | Ludmerer Steven W | Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples |
US20070299078A1 (en) * | 2006-06-26 | 2007-12-27 | Deqiang Niu | Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors |
US20080014173A1 (en) * | 2006-07-11 | 2008-01-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20090048297A1 (en) * | 2006-07-13 | 2009-02-19 | Achillion Pharmaceuticals | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
US20080107623A1 (en) * | 2006-11-01 | 2008-05-08 | Bristol-Myers Squibb Company | Inhibitors of Hepatitis C Virus |
US20090155209A1 (en) * | 2007-05-03 | 2009-06-18 | Blatt Lawrence M | Novel macrocyclic inhibitors of hepatitis c virus replication |
US20090297476A1 (en) * | 2007-05-10 | 2009-12-03 | Intermune, Inc. | Novel peptide inhibitors of hepatitis c virus replication |
US20090269305A1 (en) * | 2008-04-15 | 2009-10-29 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040191426A1 (en) * | 2003-03-26 | 2004-09-30 | Anelva Corporation | Film-forming method for forming metal oxide on substrate surface |
US20090155491A1 (en) * | 2003-03-26 | 2009-06-18 | Anelva Corporation | Film-forming method for forming metal oxide on substrate surface |
US20130078789A1 (en) * | 2011-09-22 | 2013-03-28 | Hitachi Kokusai Electric Inc. | Substrate Processing Apparatus, Method of Manufacturing Semiconductor Device and Non-Transitory Computer-Readable Recording Medium |
CN104233227A (en) * | 2014-09-23 | 2014-12-24 | 上海华力微电子有限公司 | Atomic layer deposition equipment and method |
Also Published As
Publication number | Publication date |
---|---|
US6687050B2 (en) | 2004-02-03 |
TW577123B (en) | 2004-02-21 |
US20020196531A1 (en) | 2002-12-26 |
JP2003007697A (en) | 2003-01-10 |
KR20020096860A (en) | 2002-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7488386B2 (en) | Atomic layer deposition methods and chemical vapor deposition methods | |
US7112544B2 (en) | Method of atomic layer deposition on plural semiconductor substrates simultaneously | |
US9238257B2 (en) | Method of manufacturing semiconductor device, cleaning method, and substrate processing apparatus | |
US6165916A (en) | Film-forming method and film-forming apparatus | |
US6124158A (en) | Method of reducing carbon contamination of a thin dielectric film by using gaseous organic precursors, inert gas, and ozone to react with carbon contaminants | |
JP5005170B2 (en) | Method for forming ultra-high quality silicon-containing compound layer | |
US20090130331A1 (en) | Method of Forming Thin Film and Method of Manufacturing Semiconductor Device | |
US6656282B2 (en) | Atomic layer deposition apparatus and process using remote plasma | |
JP5376361B2 (en) | Method and apparatus for manufacturing tungsten film | |
KR100539274B1 (en) | Method for depositing cobalt layer | |
US20040152254A1 (en) | Method of forming a Ta2O5 comprising layer | |
JPH10144628A (en) | Improved deposition method of thin film | |
US20050136660A1 (en) | Method of forming titanium film by CVD | |
JP2011168881A (en) | Method of manufacturing semiconductor device and substrate processing apparatus | |
JP2004096060A (en) | Film forming method | |
US7217669B2 (en) | Method of forming a metal oxide film | |
US20020197828A1 (en) | Method and apparatus for manufacturing a semiconductor device and processing a substrate | |
KR101941766B1 (en) | Substrate processing method and recording medium | |
WO2002045147A2 (en) | Method for pretreating dielectric layers to enhance the adhesion of cvd metal layers thereto | |
JP3718297B2 (en) | Thin film manufacturing method and thin film manufacturing apparatus | |
JPH05136087A (en) | Method and apparatus for growing film | |
JP2803556B2 (en) | Method of forming barrier metal layer | |
JP2004296887A (en) | Manufacturing method of semiconductor device and substrate treatment equipment | |
JP5547425B2 (en) | Process and apparatus for processing wafers | |
KR940010412B1 (en) | Method of forming thin film |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HITACHI KOKUSAI ELECTRIC INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASAI, MASAYUKI;TANAKA, TSUTOMU;REEL/FRAME:012864/0478 Effective date: 20020326 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |